2014 REU Poster: Synthesizing Antiviral Agents Effective Against Hepatitis C Virus
OA Version
Citation
Abstract
Chronic Hepatitis C Virus, or HCV, affects 120-150 million
people worldwide. HCV causes liver disease and there is not a
vaccine or an effective treatment. Previous research
indicated that two compounds, SL209 and SL205, inhibited the
dimerization of core, the capsid protein of HCV responsible for
assembling and releasing the infectious particle2. Current
research is focused on testing the effect that the structure of
these compounds has on their bioactivities, so analogues with
similar structures to SL209 and SL205 are being synthesized.
Description
Poster presentation at REU Summer's End Research Symposium, 2014, by REU participant Emelie Steck, Emory and Henry College - John Snyder group, Kyle Strom lab mentor.
License
CC0 1.0 Universal